Bisphosphonates: Potential therapeutic agents for disease modification in osteoarthritis

Aging Clinical and Experimental Research

Volumn 15, Issue 5, 2003, Pages 413-418

  Spector, Tim D ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Bisphosphonates; Bone; Cartilage; Disease modification; Osteoarthritis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; NE 10503; NE 10575; NE 11429; NE 58051; NE 97221; PHOSPHONIC ACID DERIVATIVE; RISEDRONIC ACID; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CLINICAL STUDY; CLINICAL TRIAL; DISEASE MARKER; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG STRUCTURE; DRUG TARGETING; HUMAN; MEDICAL RESEARCH; NONHUMAN; OSTEOARTHRITIS; OSTEOLYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TREATMENT PLANNING;

EID: 0345257158     PISSN: 15940667     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03327362     Document Type: Article

References (42)

1. Foss MVL, Byers PD. Bone density, osteoarthritis of the hip, and fracture of the upper end of the femur. Ann Rheum Dis 1972; 31: 259-64.
2. Radin EL, Rose RM. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop 1986; 213: 34-40.
3. McCarthy C, Cushnaghan J, Dieppe P. The predictive role of scintigraphy in radiographic osteoarthritis of the hand. Osteoarthritis Cartilage 1994; 2: 25-8.
4. Dieppe P, Cushnaghan J, Young P, Kirwan J. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis 1993; 52: 557-63.
5. Imhof H, Breitenseher M, Kainberger F, Trattnig S. Degenerative joint disease: cartilage or vascular disease? Skeletal Radiol 1997; 26: 398-403.
6. Felson DT, Chaisson CE, Hill CL, et al. The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med 2001; 134: 541-9.
7. Buckland-Wright JC, Macfarlane DG, Jasani MK, Lynch JA. Quantitative microfocal radiographic assessment of osteoarthritis of the knee from weight bearing tunnel and semiflexed standing views. J Rheumatol 1994; 21: 1734-41.
8. Hilal G, Martel-Pelletier J, Pelletier JP, Ranger P, Lajeunesse D. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis. Arthritis Rheum 1998; 41: 891-9.
9. Kouri JB, Aguilera JM, Reyes J. Apoptotic chondrocytes from osteoarthrotic human articular cartilage and abnormal calcification of subchondral bone. J Rheumatol 2000; 27: 1005-19.
10. Bailey AJ, Knott L. Molecular changes in bone collagen in osteoporosis and osteoarthritis in the elderly. Exp Gerontol 1999; 34: 337-51.
11. Westacott CI, Webb GR, Warnock MG, Sims JV, Elson CJ. Alteration of cartilage metabolism by cells from osteoarthritic bone. Arthritis Rheum 1997; 40: 1282-91.
12. Milz S, Putz R. Luckenbildung der subchondralen mineral-isiervngszone des tibiaplateaus. Osteology 1994; 3: 110-8.
13. Antonaides L, Spector TD. Comparative epidemiology of osteoarthritis and osteoporosis. In Trevs R, Ed. Osteoarthritis and osteoporosis: what is the relationship? France: Expan Science Laboratories, 2002: 9-20.
14. Hannan MT, Anderson JJ, Zhang Y, Levy D, Felson DT. Bone mineral density and knee osteoarthritis in elderly men and women. The Framingham Study. Arthritis Rheum 1993; 36: 1671-80.
15. Nevitt MC, Lane NE, Scott JC, et al. Radiographic osteoarthritis of the hip and bone mineral density. The Study of Osteoporotic Fractures Research Group. Arthritis Rheum 1995; 38: 907-16.
16. Zhang Y, Hannan MT, Chaisson CE, et al. Bone mineral density and risk of incident and progressive radiographic knee osteoarthritis in women: the Framingham Study. J Rheumatology 2000; 27: 1032-7.
17. Gotfredsen A, Riis BJ, Christiansen C, Rodbro P. Does a single local absorptiometric bone measurement indicate the overall skeletal status? Implications for osteoporosis and osteoarthritis of the hip. Clin Rheumatol 1990; 9: 193-203.
18. Li B, Aspden RM. Composition and mechanical properties of cancellous bone from the femoral head of patients with osteoporosis or osteoarthritis. J Bone Miner Res 1997; 12: 641-51.
19. Karvonen RL, Miller PR, Nelson DA, Granda JL, Fernandez-Madrid F. Periarticular osteoporosis in osteoarthritis of the knee. J Rheumatol 1998; 25: 2187-94.
20. Resnick D, Niwayama J. Diagnosis of bone and joint disorders, 2nd ed. Philadelphia: W.B. Saunders, 1988.
21. Buckland-Wright JC, Macfarlane DG, Lynch JA, Jasani MK, Bradshaw CR. Joint space width measures cartilage thickness in osteoarthritis of the knee: high resolution plain film and double contrast macroradiographic investigation. Ann Rheum Dis 1995; 54: 263-8.
22. Cumming RG, Klineberg RJ. Epidemiological study of the relation between arthritis of the hip and hip fractures. Ann Rheum Dis 1993; 52: 707-10.
23. Dequeker J, Johnell O. Osteoarthritis protects against femoral neck fracture: the MEDOS study experience. Bone 1993; 14 (Suppl 1): S51-6.
24. Arden NK, Nevitt MC, Lane NE, et al. Osteoarthritis and risk of falls, rates of bone loss, and osteoporotic fractures. Study of Osteoporotic Fractures Research Group. Arthritis Rheum 1999; 42: 1378-85.
25. Arden NK, Griffiths GO, Hart DJ, Doyle DV, Spector TD. The association between osteoarthritis and osteoporotic fracture: the Chingford Study. Br J Rheumatol 1996; 35: 1299-304.
26. Hart DJ, Cronin C, Daniels M, Worthy T, Doyle DV, Spector TD. The relationship of bone density and fracture to incident and progressive radiographic osteoarthritis of the knee: the Chingford Study. Arthritis Rheum 2002; 46: 92-9.
27. Campion GV, Delmas PD, Dieppe PA. Serum and synovial fluid osteocalcin (bone gla protein) levels in joint disease. Br J Rheumatol 1989; 28: 393-8.
28. Lohmander S. Concentrations of bone sialoprotein in joint fluid after knee injury. Transactions of the Second Combined Meeting of the Orthopaedic Research Societies of the USA, Japan, Canada and Europe, 1995: 75.
29. Hellio P, Vignon E. Comparison of urinary levels of pyridinoline and deoxypyridinoline in patients with gonarthrosis, coxarthrosis and polyarticular osteoarthritis: a cross-sectional study. The Transactions of 41st Annual Meeting of ORS, Orlando, FL. Vol. 20, Section 2: 403.
30. Bettica P, Cline G, Hart DJ, Meyer J, Spector TD. Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study. Arthritis Rheum 2002; 46: 3178-84.
31. Thompson PW, Spector TD, James IT, Henderson E, Hart DJ. Urinary collagen crosslinks reflect the radiographic severity of knee osteoarthritis. Br J Rheumatol 1992; 31: 759-61.
32. Hunter DJ, Hart D, Snieder H, Bettica P, Swaminathan R, Spector TD. Evidence of altered bone turnover, vitamin D and calcium regulation with knee osteoarthritis in female twins. Rheumatology 2003; 43: 1-6.
33. Kamibayashi L, Wyss UP, Cooke TD, Zee B. Changes in mean trabecular orientation in the medial condyle of the proximal tibia in osteoarthritis. Calcif Tissue Int 1995; 57: 69-73.
34. Kamibayashi L, Wyss UP, Cooke TD, Zee B. Trabecular microstructure in the medial condyle of the proximal tibia of patients with knee osteoarthritis. Bone 1995; 17: 27-35.
35. Lin JT, Lane JM. Bisphosphonates. J Am Acad Orthop Surg 2003; 11: 1-4.
36. Coleman RE. Bisphosphonates for the prevention of bone metastases. Semin Oncol 2002; 29 (Suppl 21): 43-9.
37. Fujita T, Fujii S. Therapeutic effects of etidronate-2-sodium (EHDP) on osteoarthritis of spine and osteoarthrosis. J New Remedies and Clinics 1997; 46: 92-102.
38. Bendele AM, Hulman JF. Spontaneous cartilage degeneration in guinea pigs. Arthritis Rheum 1988; 31: 561-5.
39. Meyer JM, Dansereau SM, Farmer RW, Jeans GL, Prenger MC. Bisphosphonates structurally similar to risedronate (actonel) slow disease progression in the guinea pig model of primary osteoarthritis. Arthritis Rheum 2001; 44 (95): 1527.
40. Meyer JM, Farmer RW, Prenger MC. Risedronate but not alendronate slows disease progression in the guinea pig model of primary osteoarthritis J Bone Miner Res 2001; 16(1S): S305.
41. Myers SL, Brandt KD, Burr DB, O'Connor BL, Albrecht M. Effects of a bisphosphonate on bone histomorphometry and dynamics in the canine cruciate deficiency model of osteoarthritis. J Rheumatol 1999; 26: 2645-53.
42. Muehleman C, Green J, Williams JM, Kuettner KE, Thonar EJ, Sumner DR. The effect of bone remodeling inhibition by zoledronic acid in an animal model of cartilage matrix damage. Osteoarthritis Cartilage 2002; 10: 226-33.